News & Updates

Show Multimedia Only
Depression may elevate CVD and all-cause death risks in patients with T2D Depression may elevate CVD and all-cause death risks in patients with T2D

Depression may elevate CVD and all-cause death risks in patients with T2D

28 Oct 2026 byKanas Chan

Depression is associated with greater risks of incident cardiovascular disease (CVD) and all-cause mortality in patients with type 2 diabetes (T2D), a population-based mediation analysis of 0.5 million Chinese people has shown.

28 Oct 2026
Switch to oral semaglutide benefits patients with overweight, obesity

Switch to oral semaglutide benefits patients with overweight, obesity

22 Oct 2026 byAudrey Abella

Individuals with overweight or obesity lost a significant amount of weight 3 months after switching from an injectable formulation of semaglutide or tirzepatide to oral semaglutide, findings from the real-world OCTANE trial have shown. The switch was also associated with high treatment adherence and satisfaction.

22 Oct 2026